BiotechTube
Home/Rubedo Life Sciences/Uri Lopatin, MD
UL

Uri Lopatin, MD

Investor (Khosla Ventures)

Rubedo Life Sciences

Therapeutic Areas

LongevityDermatologyAge-related Diseases

Rubedo Life Sciences Pipeline

DrugIndicationPhase
RLS-1496Actinic KeratosisPhase 1

Leadership Team at Rubedo Life Sciences

DF
Dr. Frederick Beddingfield III
CEO
MG
Matt Gorman, CPA
Chief Financial Officer
View full Rubedo Life Sciences profile